It's the substance of data, not how many reports come out. If there's less reports now "as you suggest" what's the holdup? The excuses for IPIX will continue to emerge as Q4 progresses. Pfizer's vaccine is out next month... The revenue possibilities for IPIX will continue to decline as delays continue. Trial needs to start in November to have any impact on the stock/company. We've seen the same record played over and over...